New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Mark Cuban: A Master Disrupter for American Health...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
High-speed imaging tracks live brain cell activity...
World is falling behind on UN's child mortality Sustainable ...
April 16,2026
Health literacy initiative improves discharge education, rea...
April 15,2026
Constipation is common, but with simple changes, you can man...
April 14,2026
Children and teenagers more open to meat free diets—but stru...
April 13,2026
3D-printed ATLAS platform helps model cancer cell clusters b...
April 12,2026
3 million-cell map shows menopause reshapes breast tissue, p...
April 11,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamiento

Los 20 tipos de cáncer más comunes: causas, síntomas y tratamientoRepasamos cuáles son los subtipos de esta enfermedad que afectan a más gente a nivel mundial.Pol Bertran PrietoMicrobiólogo, divulgado
World medicine November 28,2023
Today's News
Why is Alzheimer’s disease so difficult to treat? ...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Researchers create a drug to extend the lives of men with prostate cancer

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye
Oncology June 24,2024
Researchers create a drug to extend the lives of men with prostate cancer

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye
Oncology June 24,2024
Researchers test novel gene therapy for glioblastoma

Researchers test novel gene therapy for glioblastoma

by University Hospitals Cleveland Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and
Oncology June 24,2024
Researchers test novel gene therapy for glioblastoma

Researchers test novel gene therapy for glioblastoma

by University Hospitals Cleveland Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0A novel gene therapy clinical trial at University Hospitals Seidman Cancer Center and
Oncology June 24,2024
Multigene testing replacing BRCA tests for breast cancer risk, researcher says

Multigene testing replacing BRCA tests for breast cancer risk, researcher says

by Stanford University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014
Oncology June 24,2024
Multigene testing replacing BRCA tests for breast cancer risk, researcher says

Multigene testing replacing BRCA tests for breast cancer risk, researcher says

by Stanford University Medical CenterThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014
Oncology June 24,2024
Researchers discover coffee drinkers could halve their risk of liver cancer

Researchers discover coffee drinkers could halve their risk of liver cancer

by Queen's UniversityCredit: CC0 Public DomainA research team from Queen's University has found that coffee drinkers have a lower risk of the most common type of liver cancer, hepatocellu
Oncology June 24,2024
Researchers discover coffee drinkers could halve their risk of liver cancer

Researchers discover coffee drinkers could halve their risk of liver cancer

by Queen's UniversityCredit: CC0 Public DomainA research team from Queen's University has found that coffee drinkers have a lower risk of the most common type of liver cancer, hepatocellu
Oncology June 24,2024
Researchers take new AI approach to analyzing tumors

Researchers take new AI approach to analyzing tumors

by Karolinska InstitutetIdeas from community ecology can complement clustering-based approaches in interpreting multiplex histology data.a–cClustering can identify the cellular and ph
Oncology June 24,2024
Researchers take new AI approach to analyzing tumors

Researchers take new AI approach to analyzing tumors

by Karolinska InstitutetIdeas from community ecology can complement clustering-based approaches in interpreting multiplex histology data.a–cClustering can identify the cellular and ph
Oncology June 24,2024
Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

by National Research University Higher School of EconomicsCredit: CC0 Public DomainScientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Science
Oncology June 24,2024
Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

Researchers identify possible role of Foxp1 protein in control of autoimmune diseases

by National Research University Higher School of EconomicsCredit: CC0 Public DomainScientists at the Higher School of Economics, the Institute of Bioorganic Chemistry of the Russian Academy of Science
Oncology June 24,2024
Researchers find epigenetic loss that changes how cells obtain energy from cancer

Researchers find epigenetic loss that changes how cells obtain energy from cancer

by University of BarcelonaThe researchers Margalida Rosselló-Tortella, Manel Esteller and Pere Llinàs-Arias. Credit: UNIVERSITY OF BARCELONAIt has been known for decades that cancer cells have an
Oncology June 24,2024
Researchers find epigenetic loss that changes how cells obtain energy from cancer

Researchers find epigenetic loss that changes how cells obtain energy from cancer

by University of BarcelonaThe researchers Margalida Rosselló-Tortella, Manel Esteller and Pere Llinàs-Arias. Credit: UNIVERSITY OF BARCELONAIt has been known for decades that cancer cells have an
Oncology June 24,2024
Researchers create novel compound targeting melanoma cells

Researchers create novel compound targeting melanoma cells

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0An international team of re
Oncology June 24,2024
Researchers create novel compound targeting melanoma cells

Researchers create novel compound targeting melanoma cells

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0An international team of re
Oncology June 24,2024
Researchers define seizure burden, developmental outcomes for STXBP1-related disorders

Researchers define seizure burden, developmental outcomes for STXBP1-related disorders

by Children's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainResearchers from Children's Hospital of Philadelphia (CHOP) found that seizure patterns and response to treatment st
Neurology June 24,2024
Researchers define seizure burden, developmental outcomes for STXBP1-related disorders

Researchers define seizure burden, developmental outcomes for STXBP1-related disorders

by Children's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainResearchers from Children's Hospital of Philadelphia (CHOP) found that seizure patterns and response to treatment st
Neurology June 24,2024
Researchers find BRAF protein modification could slow tumor growth

Researchers find BRAF protein modification could slow tumor growth

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0The protei
Oncology June 24,2024
Researchers find BRAF protein modification could slow tumor growth

Researchers find BRAF protein modification could slow tumor growth

by H. Lee Moffitt Cancer Center & Research InstituteMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0The protei
Oncology June 24,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu... ... Eye Infections (Updated) | Clinical Medicine ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com